Smoking Cessation and Lung Cancer
Conditions
Brief summary
Persistent smoking after lung cancer has been the subject of medical, therapeutic and epidemiological publications for twenty years of research. Continued persistent smoking is all the more a problem for oncologists as there is evidence that smoking cessation, with lung cancer, gives therapeutic benefit. Quitting smoking can improve the response to treatments (chemotherapy, radiotherapy, surgery), quality of life and overall survival. However many patients refuse adhesion to tobacco cessation. Daily practice leads us to the hypothesis that adhesion differences aren't related to the denial of medical information, nor to resignation or to nicotine dependence. Patients who continue smoking seem to face a form of impossibility to wean. Cigarette seems to be felt as a part of their body in their narration and description of their body image.
Interventions
BEHAVIORALResearch interviews
BEHAVIORALTests (Fagerström, Q-MAT, H.A.D.S, SCL 90-R)
BEHAVIORALProjective methods (Thematic apperception Test, Rorschach)
BEHAVIORALCarbon monoxide test
Sponsors
University Hospital, Strasbourg, France
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Men and women aged 18 years or older * Patient affiliated to a social security system * Patient who has signed and dated informed consent, written before all procedures related to the study * Patient who has received the results of the previous mandatory medical examination * Patient who has been diagnosed with lung cancer, regardless of the histological type of the cancer * Patient who maintains an active smoking at the time of inclusion * Patient who has smoked at least one cigarette in the previous year of inclusion * Patient who is being treated for lung cancer (surgery, chemotherapy, radiotherapy) and not another form of cancer * Tobacco consumer's only by smoke inhalation * Tobacco consumer's or tobacco associated with cannabis
Exclusion criteria
* Major patient under guardianship or curatorship or maintenance of justice * Patient deprived of his liberty or in an emergency situation * Patient with a Performance Statut(OMS) higher than 2 and/or with a psychiatric disorder like schizophrenia and other psychotic disorders (DSM IV) * A palliative care patient * Patient who began smoking during his diagnostic examination or after the diagnosis of cancer * A pregnant or breastfeeding woman * Patient in an exclusion period
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Composite indicator variable indicating the presence or absence of disturbance in one or more of the parameters evaluated: object relations, body, subject's choice. | 2 months after inclusion | The results will be obtained: * From the results of each test, each has indeed a standardized rating scale * By analysing the content of the speech of the patient previously noted during the various interviews The investigator will classify each subject in disturbance or not for each of the three parameters. The presence of at least one disturbance gives the yes value in the indicator variable, no in the absence of the three disturbances. |
Countries
France
Outcome results
None listed